Moreover, we found that the elevated GS levels were positively associated with BCR::ABL1-independent resistance to Imatinib in CML via activation of the Cyclin D-CDK4/6 complex. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.